(Q36720925)

15 August 2017

1 reference

title

Overview of management of atrial fibrillation in symptomatic elderly patients: pharmacologic therapy versus AV node ablation (English)

1 reference

15 August 2017

1 reference

Bradley DJ

1

1 reference

15 August 2017

Shen WK

series ordinal

2

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 February 2007

1 reference

Clinical Pharmacology & Therapeutics

15 August 2017

published in

1 reference

15 August 2017

volume

81

1 reference

15 August 2017

issue

2

1 reference

15 August 2017

page(s)

284-287

1 reference

Clinical outcomes after ablation and pacing therapy for atrial fibrillation : a meta-analysis

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100062

Prospective randomized study of ablation and pacing versus medical therapy for paroxysmal atrial fibrillation: effects of pacing mode and mode-switch algorithm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100062

Assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation: a randomized controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100062

Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation: a randomized, controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100062

Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100062

7 January 2021

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiolog

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100062

7 January 2021

Validation of Clinical Classification Schemes for Predicting Stroke

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100062

7 January 2021

A comparison of rate control and rhythm control in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100062

7 January 2021

Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100062

7 January 2021

Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100062

7 January 2021

Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100062

7 January 2021

Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100062

7 January 2021

Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100062

7 January 2021

The Australian Intervention Randomized Control of Rate in Atrial Fibrillation Trial (AIRCRAFT).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100062

7 January 2021

Prospective, randomized study of atrioventricular ablation and mode-switching, dual chamber pacemaker implantation versus medical therapy in drug-resistant paroxysmal atrial fibrillation. The PAF study. Paroxysmal Atrial Fibrillation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100062

7 January 2021

Importance of rate control or rate regulation for improving exercise capacity and quality of life in patients with permanent atrial fibrillation and normal left ventricular function: a randomised controlled study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100062

7 January 2021

Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100062

7 January 2021

Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100062

7 January 2021

The effect of cardiac resynchronization on morbidity and mortality in heart failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100062

7 January 2021

Identifiers

DOI

10.1038/SJ.CLPT.6100062

1 reference

15 August 2017

1 reference